title: Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.
abstract: Although sildenafil citrate (SC) is used extensively for erectile dysfunction, oral delivery of SC encounters many obstacles. Furthermore, the physicochemical characteristics of this amphoteric drug are challenging for delivery system formulation and transdermal permeation. This article concerns the assessment of the potential of nanomedicine for improving SC delivery and transdermal permeation. SC-loaded nanostructured lipid carriers (NLCs) and solid lipid nanoparticles (SLNs) were fabricated using a modified high-shear homogenization technique. Nanoparticle optimization steps included particle size analysis, entrapment efficiency (EE) determination, freeze-drying and reconstitution, differential scanning calorimetry, in vitro release, stability study and high-performance liquid chromatography analysis. Transdermal permeation of the nanocarriers compared with SC suspension across human skin was assessed using a modified Franz diffusion cell assembly. Results revealed that SLNs and NLCs could be optimized in the nanometric range (180 and 100 nm, respectively) with excellent EE (96.7% and 97.5%, respectively). Nanoparticles have significantly enhanced in vitro release and transdermal permeation of SC compared with its suspensions. Furthermore, transdermal permeation of SC exhibited higher initial release from both SLN and NLC formulations followed by controlled release, with promising implications for faster onset and longer drug duration. Nanomedicines prepared exhibited excellent physical stability for the study period. Solid nanoparticles optimized in this study successfully improved SC characteristics, paving the way for an efficient topical Viagra® product.
authors.affiliation: Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt. yosra_pharm@yahoo.com
authors.forename: Yosra S R
authors.initials: YS
authors.lastname: Elnaggar
authors.forename: Magda A
authors.initials: MA
authors.lastname: El-Massik
authors.forename: Ossama Y
authors.initials: OY
authors.lastname: Abdallah
mesh_terms: D000279:Administration, Cutaneous; D002626:Chemistry, Pharmaceutical; D004337:Drug Carriers / Q000737:chemistry*; D004355:Drug Stability; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008055:Lipids / Q000008:administration & dosage / Q000737:chemistry* / Q000493:pharmacokinetics; D050997:Nanomedicine; D053758:Nanoparticles / Q000737:chemistry; D049329:Nanostructures / Q000008:administration & dosage / Q000737:chemistry*; D036103:Nanotechnology; D010168:Palmitates / Q000737:chemistry; D010316:Particle Size; D010879:Piperazines / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics*; D011687:Purines / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D000068677:Sildenafil Citrate; D012867:Skin / Q000378:metabolism*; D012869:Skin Absorption; D013450:Sulfones / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics*; D046509:Tissue Culture Techniques
chemical_list: D004337:Drug Carriers; D008055:Lipids; D010168:Palmitates; D010879:Piperazines; D011687:Purines; D013450:Sulfones; C006957:cetyl palmitate; D000068677:Sildenafil Citrate